CGT Therapy Forum at the 8th Future Healthcare Ecological Fair Unveils Lineup and Strategic Vision

In recent years, the cellular and gene therapy (CGT) industry has witnessed unprecedented growth. Currently, more than 50 CGT therapies have been approved for market launch worldwide. In China, a wave of CGT therapies was intensively launched in 2023, and multiple domestic companies have advanced their CGT candidate products from preclinical to clinical stages, signaling the rapid development of the CGT industry.

Meanwhile, the CGT industry continues to face numerous challenges in technological innovation, industrial development, and commercial translation. Issues such as product quality and batch-to-batch consistency, along with the tension between high costs and high pricing that limits accessibility, underscore the urgent need for optimization and iteration of CGT products. Furthermore, the importance of Chemistry, Manufacturing, and Controls (CMC) cannot be overlooked. It is the vision of every CGT enterprise to design superior products, reduce costs while enhancing efficiency, and develop efficacious therapies. Consequently, supply chain service providers and high-quality suppliers have become significant drivers of industrial upgrading.

May 7–10, 2024, the 8th Future Healthcare Ecosystem Expo will be held at the Beijing·Beiren Yichuang International Convention and Exhibition Center. The event is organized by VB100, VCBeat, Eggshell Research Institute, and Arterial Orange, co-organized by the Tianjin Economic-Technological Development Area (TEDA), and strategically partnered with the Management Committee of Tianjin Binhai Zhongguancun Science Park and Beitang Bay Digital Economy Industrial Park. During this period,CGT Therapy Forum and [No Need to Compete, Go Further] CGT Industry Upgrade [VBEF] Stop Will Be Held on the Afternoon of May 9，Co-hosted by VCBeat New Medicine and Hangzhou Xingcheng Biotechnology, and supported by Panlin Capital and Fosun Health Capital, this sub-forum brought together more than 20 distinguished guests from government, industry, academia, research, healthcare, and investment sectors to engage in in-depth discussions on upgrading the CGT industry and driving it toward higher levels of development.。

As the cell and gene therapy (CGT) industry expands rapidly, new challenges are emerging for industry participants. For instance, in an increasingly competitive market environment, how can developers accurately understand and meet clinical needs? During the clinical application phase, where does the true value of supply chain enterprises lie, and how can they facilitate process development and stable scale-up manufacturing of CGT products? Under these new circumstances, how can diverse innovative resources achieve industrial integration to promote the cohesive development of the CGT industry chain?

In response to the aforementioned issues and challenges, this sub-forum has convened renowned experts, leading enterprises, investment institutions, and other stakeholders to pool innovative resources. It establishes a platform for cross-sector dialogue, collaboration, and advocacy within the cell and gene therapy (CGT) industry. By focusing on the development direction and strategies of the CGT sector, the forum aims to provide momentum and a solid foundation for CGT innovative pharmaceutical companies throughout their product R&D lifecycle and industrial upgrading journey, from diverse perspectives, thereby facilitating the translation and practical application of new technological achievements.

Forum Agenda:

CGT products are currently breaking boundaries across multiple dimensions, gradually addressing unmet clinical needs in various areas. The FDA projects that 10–20 CGT products will be approved for market entry annually starting in 2025. This has instilled significant confidence and expectation in the market, attracting diverse stakeholders to enter the field and expand into different disease indications, potentially ushering in a “golden decade” for CGT. What development opportunities and challenges lie ahead for the CGT industry, and what stories of growth will unfold? In Beijing, at the forefront of China’s medical advancements, we look forward to meeting you to jointly explore the challenges and future of the CGT landscape.

May 9, Beijing. See you there!

Conference Registration QR Code:

Event Time: May 9, 2024 (13:30-17:00)

Venue: Beijing · Beiren Yichuang International Convention and Exhibition Center